Literature DB >> 1752961

Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein.

M Navab1, S S Imes, S Y Hama, G P Hough, L A Ross, R W Bork, A J Valente, J A Berliner, D C Drinkwater, H Laks.   

Abstract

Incubation of cocultures of human aortic endothelial (HAEC) and smooth muscle cells (HASMC) with LDL in the presence of 5-10% human serum resulted in a 7.2-fold induction of mRNA for monocyte chemotactic protein 1 (MCP-1), a 2.5-fold increase in the levels of MCP-1 protein in the coculture supernatants, and a 7.1-fold increase in the transmigration of monocytes into the subendothelial space of the cocultures. Monocyte migration was inhibited by 91% by antibody to MCP-1. Media collected from the cocultures that had been incubated with LDL induced target endothelial cells (EC) to bind monocyte but not neutrophil-like cells. Media collected from cocultures that had been incubated with LDL-induced monocyte migration into the subendothelial space of other cocultures that had not been exposed to LDL. In contrast, media from separate cultures of EC or smooth muscle cells (SMC) containing equal number of EC or SMC compared to coculture and incubated with the same LDL did not induce monocyte migration when incubated with the target cocultures. High density lipoprotein HDL, when presented to cocultures together with LDL, reduced the increased monocyte transmigration by 91%. Virtually all of the HDL-mediated inhibition was accounted for by the HDL2 subfraction. HDL3 was essentially without effect. Apolipoprotein AI was also ineffective in preventing monocyte transmigration while phosphatidylcholine liposomes were as effective as HDL2 suggesting that lipid components of HDL2 may have been responsible for its action. Preincubating LDL with beta-carotene or with alpha-tocopherol did not reduce monocyte migration. However, pretreatment of LDL with probucol or pretreatment of the cocultures with probucol, beta-carotene, or alpha-tocopherol before the addition of LDL prevented the LDL-induced monocyte transmigration. Addition of HDL or probucol to LDL after the exposure to cocultures did not prevent the modified LDL from inducing monocyte transmigration in fresh cocultures. We conclude that cocultures of human aortic cells can modify LDL even in the presence of serum, resulting in the induction of MCP-1, and that HDL and antioxidants prevent the LDL induced monocyte transmigration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752961      PMCID: PMC295797          DOI: 10.1172/JCI115532

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture.

Authors:  A J Valente; D T Graves; C E Vialle-Valentin; R Delgado; C J Schwartz
Journal:  Biochemistry       Date:  1988-05-31       Impact factor: 3.162

4.  High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjects.

Authors:  F C Ballantyne; R S Clark; H S Simpson; D Ballantyne
Journal:  Metabolism       Date:  1982-05       Impact factor: 8.694

5.  Isolation, purification, and characterization of a lipoprotein containing Apo B from the human aorta.

Authors:  H F Hoff; J W Gaubatz
Journal:  Atherosclerosis       Date:  1982-04       Impact factor: 5.162

6.  Minimally modified low density lipoprotein is biologically active in vivo in mice.

Authors:  F Liao; J A Berliner; M Mehrabian; M Navab; L L Demer; A J Lusis; A M Fogelman
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

7.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

8.  Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message.

Authors:  M Navab; F Liao; G P Hough; L A Ross; B J Van Lenten; T B Rajavashisth; A J Lusis; H Laks; D C Drinkwater; A M Fogelman
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

9.  The antioxidant butylated hydroxytoluene protects against atherosclerosis.

Authors:  I Björkhem; A Henriksson-Freyschuss; O Breuer; U Diczfalusy; L Berglund; P Henriksson
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

10.  High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

Authors:  J Johansson; L A Carlson; C Landou; A Hamsten
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb
View more
  158 in total

1.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.

Authors:  K Ishikawa; M Navab; N Leitinger; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  [Non-lipid effects of statins: myth or fact?].

Authors:  Eleonora Urbauer; Christian Joukhadar
Journal:  Wien Med Wochenschr       Date:  2003

Review 4.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Authors:  Menno Vergeer; Adriaan G Holleboom; John J P Kastelein; Jan Albert Kuivenhoven
Journal:  J Lipid Res       Date:  2010-04-06       Impact factor: 5.922

6.  Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.

Authors:  David O Osei-Hwedieh; Marcelo Amar; Dmitri Sviridov; Alan T Remaley
Journal:  Pharmacol Ther       Date:  2010-12-21       Impact factor: 12.310

7.  A biochemical fluorometric method for assessing the oxidative properties of HDL.

Authors:  Theodoros Kelesidis; Judith S Currier; Diana Huynh; David Meriwether; Christina Charles-Schoeman; Srinivasa T Reddy; Alan M Fogelman; Mohamad Navab; Otto O Yang
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

8.  Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

Authors:  Nosratola D Vaziri; Kaveh Navab; Pavan Gollapudi; Hamid Moradi; Madeleine V Pahl; Cyril H Barton; Alan M Fogelman; Mohamad Navab
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

9.  HDL and electronegative LDL exchange anti- and pro-inflammatory properties.

Authors:  Cristina Bancells; José Luis Sánchez-Quesada; Ragnhild Birkelund; Jordi Ordóñez-Llanos; Sònia Benítez
Journal:  J Lipid Res       Date:  2010-07-20       Impact factor: 5.922

10.  Serum carotenoids and vitamins in relation to markers of endothelial function and inflammation.

Authors:  Wendy M R van Herpen-Broekmans; Ineke A A Klöpping-Ketelaars; Michiel L Bots; Cornelis Kluft; Hans Princen; Henk F J Hendriks; Lilian B M Tijburg; Geert van Poppel; Alwine F M Kardinaal
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.